Ancient chinese herb berberine tested to stop heart disease and diabetes in its tracks

NCT ID NCT05749874

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large, phase 4 trial is testing whether berberine, a natural compound, can prevent heart disease and diabetes in over 2,000 high-risk adults in China. Participants take berberine or a placebo twice daily, plus receive lifestyle advice. The study tracks blood sugar and heart health over time to see if berberine reduces the risk of developing these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
berberine hydrochloride
What this could lead to
If it works, this could point toward a simple, affordable supplement to help prevent heart disease and diabetes in people at high risk.
What could go wrong
This is a single large trial in China, so results may not apply to other populations. Berberine can cause digestive side effects and may interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.